Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T10:09:59.721Z Has data issue: false hasContentIssue false

On the distribution of a fluorescent ivermectin probe (4″ 5,7 dimethyl-bodipy proprionylivermectin) in Ascaris membranes

Published online by Cambridge University Press:  06 April 2009

R. J. Martin
Affiliation:
Department of Pre-clinical Veterinary Sciences, R.(D.) S.V.S. Summerhall, University of Edinburgh, Edinburgh EH9 IQH
J. R. Kusel
Affiliation:
Department of Biochemistry, University of Glasgow, Glasgow

Extract

The distribution of the fluorescent ivermectin derivative (4″ 5,7 dimethyl bodipy proprionylivermectin, referred to here as bodipy ivermectin) was studied in muscle vesicle membranes from the parasite Ascaris suum. Incubation in bodipy ivermectin, at concentrations greater than 1 ng/ml, produced a dose-dependent fluorescence in the vesicles. The level of fluorescence was not depressed (but increased) by prior incubation with 1 μM unlabelled ivermectin. This observation suggested that most of the bodipy ivermectin was free in the lipid phase of the membrane and not associated with a receptor. The trypan blue quenching technique showed that the bodipy ivermectin did not cross the membrane bilayer but remained in the outer monolayer. Lateral mobility of the probe in the membrane was studied using the fluorescence recovery after photobleaching (FRAP) technique. The lateral diffusion coefficient (DL) was 14.0 x 10−10 cm2/s which was nearly three times faster than the lipid probe octadecanoyl-aminofluorescein in membranes from the same preparations; only 46% of the probe was mobile, showing that within a 1.2 μm radius the distribution of the bodipy ivermectin in the membrane was not homogeneous. These observations are used to suggest that: the site of action of livermectin is located in the outer monolayer of the membrane (possibly on the Cl channel); and that the speed of onset of action in isolated membrane preparations may be limited by diffusion in the membrane.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Axelrod, D. D., Koppel, E., Schlessinger, J., Elson, J. & Webb, W. W. (1976). Mobility measurement and analysis of fluorescence photobleaching recovery kinetics. Biophysics Journal 16, 1055–69.CrossRefGoogle ScholarPubMed
Burg, R. W., Miller, B. M., Baker, E. E., Birnbaum, J., Currie, J. A., Hartman, R., Kong, Y.-L., Monaghan, R. L., Olsen, G., Putter, I., Tunac, J. P., Wallick, H., Stapley, E. O., Oiwa, A. R. & Omura, S. (1979). Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrobial Agents for Chemotherapy 15, 361–7.CrossRefGoogle ScholarPubMed
Cambell, W. C. & Benz, G. W. (1984). Ivermectin: a review of efficacy and safety. Journal of Veterinary Pharmacology and Therapeutics 7, 116.Google Scholar
Duce, I. R. & Scott, R. H. (1985). Actions of dihydroavermectin Bla on insect muscle. British Journal of Pharmacology 85, 395401.CrossRefGoogle Scholar
Fisher, M. H. & Mrozik, H. (1984). The avermectin family of macrolide-like antibiotics. In Macrolide Antibiotics (ed. Omura, S.), pp. 553606. New York: Academic Press.Google Scholar
Foley, M., Macgregor, A. N., Kusel, J. R., Garland, P. B., Downie, T. & Moore, I. (1986). The lateral diffusion of lipid probes in the surfaces ofSchistosoma mansoni. Journal of Cell Biology 103, 807–18.Google Scholar
Fritz, L. C., Wang, C. C. & Gorio, A. (1979). Avermectin Bla irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proceedings of the National Academy of Sciences, USA 76, 2062–6.CrossRefGoogle Scholar
Garland, P. B. (1981). Fluorescence photobleaching recovery: control of laser intensities with an acoustico-optic modulator. Biophysics Journal 33, 481–2.CrossRefGoogle ScholarPubMed
Housley, M. D. & Stanley, K. K. (1982). Dynamics of Biological Membranes. Chichester: John Wiley and Sons.Google Scholar
Kass, I. S., Larsen, D. A., Wang, C. C. & Stretton, A. O. W. (1982). Ascaris suum: differential effects of avermectin Bla on the intact animal and neuromuscular strip preparations. Experimental Parasitology 54, 166–74.Google Scholar
Martin, R. J. (1980). The effect of γ-aminobutyric acid on the input conductance and membrane potential of Ascaris muscle. British Journal of Pharmacology 71, 99106.Google Scholar
Martin, R. J., Kusel, J. R. & Pennington, A. J. (1990). Surface properties of membrane vesicles prepared from muscle cells of Ascaris suum. Journal of Parasitology 76, 340–8.CrossRefGoogle ScholarPubMed
Martin, R. J. & Pennington, A. J. (1989). A patch-clamp study of effects of dihydroavermectin on Ascaris muscle. British Journal of Pharmacology 98, 747–56.CrossRefGoogle ScholarPubMed
Mellin, T. N., Busch, R. D. & Wang, C. C. (1983). Postsynaptic inhibition of invertebrate neuromuscular transmission by avermectin Bla. Neuropharmacology 22, 8996.Google Scholar
Saffman, P. G. & Dellbruck, M. (1975). Brownian motion in biological membranes. Proceedings of the National Academy of Sciences, USA 72, 3111–13.CrossRefGoogle ScholarPubMed
Schaeffer, J. M. & Haines, H. W. (1989). Avermectin binding in Caenorhabditis elegans: a two-state model for the avermectin binding site. Biochemical Pharmacology 38, 2329–39.CrossRefGoogle ScholarPubMed
Schaeffer, J. M., Stiffy, J. H. & Mrozik, H. (1989). A chemiluminescent assay for measuring avermectin binding sites. Analytical Biochemistry 177, 291–5.Google Scholar
Wolf, D. E., Kinsey, W., Lennarz, W. & Edidin, M. (1981). Changes in the organization of sea urchin egg plasma membrane upon fertilization: indications from lateral diffusion rates of lipid soluble fluorescent dyes. Developmental Biology 18, 133–8.Google Scholar